ISRCTN ISRCTN77876347
DOI https://doi.org/10.1186/ISRCTN77876347
Secondary identifying numbers RA/4/1/1109
Submission date
15/04/2005
Registration date
10/05/2005
Last edited
08/09/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Sean Hood
Scientific

School of Psychiatry and Clinical Neurosciences (M521)
Queen Elizabeth II Medical Centre
Nedlands
Perth
6009
Australia

Phone +61 (0)8 93462393
Email sean@cyllene.uwa.edu.au

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study objectives1. Tryptophan depletion will increase the anxiogenic response to single breath 35% CO2 in normal volunteers, as compared with an air inhalation.
2. Single breath 35% CO2 inhalation in normal volunteers will induce cortisol and prolactin release.
3. Tryptophan depletion will significantly increase the magnitude of single breath 35% CO2 induced cortisol and prolactin release in normal volunteers.
4. Tryptophan depletion will exacerbate single breath 35% CO2 inhalation induced hypertension and bradycardia in normal volunteers.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedStress/Anxiety
Intervention1. Tryptophan depletion, double-blind crossover with Tryptophan restored intervention
2. Single breath 35% CO2 inhalation single blind crossover with single breath room air
Intervention typeOther
Primary outcome measureVisual Analogue rating Scales (VAS), The Spielberger State Anxiety Inventory (STAI), Cortisol & tryptophan levels.
Secondary outcome measuresThe Panic Symptom Inventory (PSI), Prolactin levels, Blood pressure/heart rate data, Swedish universities Scales of Personality (SSP)
Overall study start date01/04/2005
Completion date31/07/2005

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
Lower age limit18 Years
Upper age limit65 Years
SexBoth
Target number of participants14
Key inclusion criteria1. Healthy volunteers aged 18-65
2. Able & willing to give informed consent prior to participation
Key exclusion criteriaAny psychiatric morbidity by GP report, psychiatric clinical
interview, or MINI v5 (Sheehan et al. 1998) semi-structured interview
Date of first enrolment01/04/2005
Date of final enrolment31/07/2005

Locations

Countries of recruitment

  • Australia

Study participating centre

School of Psychiatry and Clinical Neurosciences (M521)
Perth
6009
Australia

Sponsor information

University of Western Australia (Australia)
University/education

35 Stirling Highway
Nedlands
Perth
6009
Australia

Email kkirk@admin.uwa.edu.au
Website http://www.uwa.edu.au/
ROR logo "ROR" https://ror.org/047272k79

Funders

Funder type

University/education

University of Western Australia Research Grants Scheme 2004 (Australia) (ref: RA/1/485/)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/10/2006 Yes No